Neuronal death, which follows ischemic injury or is triggered by excitotoxins, can occur by both apoptosis and necrosis. Caspases, which are not directly required for necrotic cell death, are central mediators of the apoptotic program. Here we demonstrate that caspases cleave and inactivate the plasma membrane Ca 2+ pump (PMCA) in neurons and non-neuronal cells undergoing apoptosis. PMCA cleavage impairs intracellular Ca 2+ handling, which results in Ca 2+ overload. Expression of non-cleavable PMCA mutants prevents the disturbance in Ca 2+ handling, slows down the kinetics of apoptosis, and markedly delays secondary cell lysis (necrosis). These findings suggest that caspase-mediated cleavage and inactivation of PMCAs can lead to necrosis, an event that is reduced by caspase inhibitors in brain ischemia.
Introduction
The apoptotic death program seems to converge mainly on one class of proteases, the caspases (cysteine aspartases), which can execute death signals in virtually every cell (see 1, 2 for reviews). Based on their substrate specificity, the caspase gene family can be subdivided into three major groups: group I caspases-1, -4, -5, -13 are predominantly involved in cytokine processing and therefore in inflammatory processes; group II caspases-2, -3, -7) are considered the major effectors of death signals (execution caspases); group III caspases-6, -8, -9, -10 are upstream activators of the group II caspases. Recent work indicates that the murine caspase-11, which shares homology with human caspase-4, can also activate caspase-1 and caspase-3. 3 Many of the caspase substrates are responsible for the appearance of the characteristic apoptotic features (i.e., DNA laddering, nuclear envelope breakdown, cell shrinkage and exposure of phosphatidylserines). Whereas inhibition of effector caspases prevents the appearance of the apoptotic morphology in most cases, it does not always preclude the occurrence of cell death that may be triggered by other programmes/pathways. 4, 5 With the notable exception of group III caspases, which are linked to death domains, 6 and act upstream of the processes involved in both apoptosis and necrosis, 7 this family of proteases does not apparently execute death forms other than apoptosis. Nevertheless, caspase inhibition reduces the overall rate of cell death in ischemic stroke models, 8 ± 10 where the necrotic morphology is predominant. 11, 12 Reduction of caspase-dependent pro-inflammatory reactions 13 ± 15 or involvement of death receptors and group III caspases 16, 17 may partly explain the global protective effect (i.e., prevention of both apoptosis and necrosis) of broad-spectrum caspase inhibitors in vivo. A yet more selective inhibition of either group II or group I caspases shows intriguing differences: caspase-1 inhibition by YVAD.cmk reduces both the size of brain infarcts and brain swelling, whereas inhibition of caspase-3 by DEVDfmk reduces brain infarcts, but not swelling after middle cerebral artery occlusion. 13 These observations, along with experiments using different, more selective strategies to inhibit caspase-3 10 , suggest that inhibitors of group II caspases can protect against both apoptosis and necrosis in stroke models. Caspase inhibition can stave-off the breakdown of the cell membrane, which follows the execution of other typical degradative processes of apoptosis. Eventually, cells can lyse even after the apoptotic morphology has been accomplished, and a necrotic phenotype may ensue if scavenging of dying cells is insufficient. This secondary necrosis has been observed after liver injury 18 and is common in in vitro models of apoptosis. The signals leading to secondary lysis or necrosis are unknown. Osmotic imbalance intervening in doomed cells may lead to cell rupture. Such an ionic imbalance may result from gain and/or loss of function in ion channels and exchangers brought about by protease activation. Previous studies in neurons have shown that Ca 2+ -permeable glutamate receptors of the AMPA-subtype can be cleaved by caspases. 19 Their inactivation would avoid excitotoxicity and Ca 2+ overload in neurons destined to apoptose. 20 While cleavage of AMPA channels and loss of Ca 2+ conductance may prevent the lethal effects of Ca 2+ overload and a potential switch from apoptosis to necrosis, inhibition of cellular Ca 2+ efflux would ensue in Ca 2+ overload and cell death. 21 Intracellular Ca 2+ overload can set off cell demise via Ca 2+ -dependent processes 22 , change the balance of neuronal death from apoptosis to necrosis by depleting energy stores, 23 or augment other death execution mechanisms. For instance, Ca 2+ -binding proteins e.g. calcineurin, can mobilize pro-apoptotic proteins to mitochondria, 24 and the interplay between Ca 2+ -activated proteases and caspases may amplify apoptotic signals. 25 Since the integrity of plasma membrane Ca 2+ ATPase (PMCA) is essential to rectify changes in intracellular Ca 2+ in the long-term, we decided to investigate the fate of calcium translocases in cells undergoing apoptosis. Independent genes encode the four major PMCA isoforms currently known. Another Ca 2+ pump is located in the endo-/sarcoplasmic reticulum (SERCA). PMCA isoforms 1 and 4 are expressed ubiquitously in mammalian cells, whereas isoforms 2 and 3 are expressed in significant amounts only in the brain. 26 In this study, we demonstrate that both the neuron specific PMCA2 and the ubiquitous PMCA4 isoforms are cleaved by caspases. PMCA2 is cleaved in vivo following brain ischemia and in neurons undergoing apoptosis after excitotoxic stimulation. PMCA4 is cleaved in non-neuronal cells induced to apoptose by staurosporine. Cleavage of PMCAs results in loss of function and aberrant intracellular Ca 2+ transients. Expression of mutants of human PMCA4 that lack the caspase cleavage site(s) prevents Ca 2+ overload during apoptosis and markedly delays secondary cell lysis/necrosis. These findings provide a possible explanation for the observation that caspase inhibitors prevent the appearance of secondary necrosis in stroke models, and rescue ischemic areas.
Results
Cleavage of PMCA2 in brain ischemia and in excitotoxin-induced apoptosis At variance with the other neuronal isoform PMCA3, PMCA2 is reasonably well characterized. It participates in the neuronal developmental program and fully differentiated neurons express it in high amounts. 26 To investigate the fate of PMCA2 during brain ischemia, neonatal P7 rats received left common carotid artery ligation and were exposed to 8% oxygen/92% nitrogen for 2.5 h. Western blot of lysates obtained from cortical samples showed that PMCA2 (133 kDa) was degraded to a main fragment of 123 kDa ( Figure 1 ). The extent of pump cleavage was related to the degree of brain injury as assessed by brain swelling and to the apoptotic index, which reflects apoptotic DNA fragmentation.
Neonatal hypoxia-ischemia is characterized by the presence of apoptotic features and the activation of the caspase execution machinery. 27 To investigate whether PMCA2 was cleaved during excitoxin-induced apoptosis, CGN were exposed to either low concentrations of the direct excitotoxin glutamate, or to the indirect excitotoxins, S-nitrosoglutathione (GSNO) or 1-methyl-4-phenylpyridinium (MPP + ), which stimulate synaptic glutamate release and excitotoxicity. 28, 29 Western blots of membrane fractions isolated from CGN undergoing apoptosis, showed that PMCA2 (133 kDa) was degraded to the same 123 kDa fragment found in the ischemic brain tissue (Figure 2A ). Neurons pre-treated with the NMDA (N-methyl-D-aspartate)-receptor blocker, MK-801 (5-methyl-10, 11-dihydro-5H-dibenzo [a, d] cycloheptene-5, 10-imine hydrogen Figure 1 Cleavage of PCMA2 in brain ischemia. Neonatal P7 Sprague-Dawley rats underwent hypoxic injury as described in Materials and Methods. Brains were removed and scored for degree of injury (Brain Injury Index) and the extent of PCMA2 cleavage (p123) and apoptotic DNA fragmentation (fDNA) were assessed in the ipsilateral cortices. Data are the average+S.E. except (n=13) for columns 3 where n=1. A representative Western blot of PCMA cleavage, comparing injury extremes (0 versus 3), is shown as an inset maleate), which prevents cell death in this model, also prevented PMCA2 cleavage. Similarly, the pan-caspase inhibitors z-D-cbk and Ac-YVAD-cho blocked PMCA2 cleavage ( Figure 2B ). Both caspase inhibitors prevented neuronal apoptosis elicited by indirect excitotoxicity in CGN. 29, 30 To further investigate the cleavage of PMCA2, the plasma membrane enriched fraction was isolated from a clone of insect Sf9 cells that stably expresses human (h)PMCA2. We opted for the membrane preparation as opposed to the purified pump to study the pump in its regularly inserted and folded state. Membranes were exposed to caspases at 378C for 1 h. The pump (molecular mass about 133 kDa) was cleaved by caspase-1, by caspase-3 and, to a lesser extent, by caspase-7 ( Figure  2C ). The cleavage of the pump by caspase-1 yielded a major fragment of about 40 kDa and two less abundant fragments of about 35 and 33 kDa. Caspase-3 produced fragments ranging in size between 40 and 43 kDa, whereas caspase-7 yielded only a minor fragment of about 40 kDa. Other caspases (i.e., 4 and 8) were ineffective.
Calcium pumps are P-type ATPases, i.e., they form a phosphorylated intermediate during the reaction cycle, 31 which is used to determine pump activity. The phosphoenzyme formation was measured in membrane fractions from Sf-9 cells incubated with purified caspase-1, in the presence of g 32 P-labeled ATP. The phosphorylated band decreased already after 5 min of incubation, and became undetectable after 15 min ( Figure 2D ). Thus, the cleavage of PMCA2 by caspase-1 led to its inactivation. Since the membrane preparation used in these experiments also contained significant amounts of the SERCA, we tested whether the formation of the phosphorylated intermediate by the latter was also affected by caspases. Caspase-1 (as well as the other caspases tested above) did not cleave and/or inactivate the SERCA pump ( Figure 2D ).
Cleavage and inactivation of PMCA4 in vitro and in cells undergoing apoptosis
To examine whether the ubiquitous pump isoform was also a substrate for caspases, we initially isolated membrane fractions from Sf9 cells expressing hPMCA4. Caspase-3, and somewhat less effectively caspase-7, cleaved the 134 kDa PMCA4 to a product of about 119 kDa. Interestingly, at variance with PMCA2, caspase-1 was ineffective ( Figure  3A) .
The effect of caspase cleavage on PMCA4 activity was explored as described for PMCA2 ( Figure 3B ). The global pump activity as expressed by the phosphorylated intermediate, decreased and was virtually lost after 30 min in the presence of purified caspase-3.
To investigate whether the pump was cleaved in apoptosis, we chose two independent CHO cell clones (925 and 10150) that stably overexpress hPMCA4. Both were exposed to 1 mM staurosporine (STS), 32 which elicited apoptosis in about 35 ± 50% of the cells after 5 h. Following caspase-3 activation (detected by DEVDase activity; not shown), membrane fractions were isolated from untreated cells, cells treated with STS, or cells treated with STS combined with the caspase inhibitor z-VAD-fmk; hPMCA4 was cleaved to the 119 kDa fragment in STS-treated clones, but not in clones treated with STS+z-VAD ( Figure  3C ). Identification of the caspase-3 cleavage site on PMCA4
Next, we attempted to identify the caspase cleavage site on hPMCA4. The hPMCA4 was selected because of the availability of deletion mutants and antibodies that recognize specifically either the N-or the C-terminal domains of the protein. 33 Crude membrane fractions were isolated from the clones 925 and 10150, as well as from a vector-transfected clone (4150) and wild-type CHO cells. Membranes were exposed to purified caspase-3 for 1 h at 378C. Since the antibody against hPMCA4 does not recognize the hamster PMCA4, no bands were detected in Western blots in the wt and vector-transfected clones ( Figure 4A ). Membrane fractions from the cell clones 925 and 10150, incubated with caspase-3, exhibited both the intact pump and its degradation product of 119 kDa, as in Sf-9/PMCA4 membrane fractions and in CHO cells undergoing apoptosis. The anti-PMCA4 antibody used in previous experiments recognizes a relatively small epitope in the N-terminal portion of the pump. Since we did not detect small PMCA4 fragments after caspase cleavage in CHO cells, the cleavage site was evidently not located in the proximity of the N-terminus. In contrast, an antibody raised against the C-terminal domain of the human PMCA4 recognized a fragment of about 25 kDa ( Figure 4B ). The caspase-3 cleavage site on PMCA4 was further characterized by using deletion mutants with different C-terminal truncations.
34 PMCA4 consists of 1205 amino acids. The D44 mutant lacks the 44 C-terminal residues, (from phenylalanine 1162 to valine 1205), whereas the D139 mutant lacks the 139 C-terminal residues (from glutamic acid 1067 to valine 1205). Both mutants were subjected to in vitro cleavage with purified caspase-3, using the full length PMCA4 as a control. While the D44 mutant was still cleaved, the D139 mutant was not ( Figure 4C ), which suggested that the cleavage site was located between glutamic acid 1067 and phenylalanine 1162. In addition, the degradation band from the full-length PMCA4 was approximately 1 kDa larger than the native band of the D139 mutant, restricting potential cleavage sites to the DEID sequence between D1077 and D1080. Proteins from Sf-9 membrane fractions containing hPMCA4 were incubated either with buffer alone (outer left lane) or with purified caspases-1, -3, -4, -7 or -8 as described for PMCA2. Samples were separated on SDS-gels, blotted on nitrocellulose, and probed with a polyclonal anti-hPMCA4 antibody. (B) The activity of hPMCA4 was measured after incubation with purified caspase-3 as described for hPMCA2 (see Figure  1 ). The main phosphorylated band corresponding to the intact pump decreased after 15 min and virtually disappeared after 30 min. Concomitantly, a phosphorylated band corresponding to the degradation product PMCA4* appeared in the autoradiography. Therefore, this fragment might have residual pump activity. However, since the pump is cleared from the plasma membrane after caspase cleavage (see Figure 5 ), it is highly unlikely that PMCA4* could pump Ca 2+ outside the cell. (C) CHO cells overexpressing hPMCA4 were treated with staurosporine (STS). Two independent clones (925 and 10150) were triggered to apoptose by STS (1 mM). Membrane fractions were isolated after 5 h and prepared for SDS ± PAGE and immunoblotting. PMCA is cleaved to a 119 kDa product (PMCA*) recognized by an antibody raised against the pump N-terminal domain. Pre-treatment with the caspase inhibitor z-VAD-fmk abolished cleavage
Expression of PMCA4 mutants non-cleavable by caspases
Both aspartic acid residues in the sequence D 1077 EID 1080 were mutated to alanine residues (see scheme in Figure 5A ). CHO cells were then transfected with the mutant plasmids and clones were selected for expression of the D1080A (A) or D1077A (B) mutants. Membrane fractions were then analyzed by Western blotting. Both mutant clones reacted with an antibody that recognizes the full-length human PMCA4 ( Figure 5B ). CHO clones that stably overexpress wild-type hPMCA4 (clone 925) and human cells (HeLa) that constitutively express PMCA4 were used as controls. All cell clones were then stimulated with 1 mM STS to undergo apoptosis. hPMCA4 was cleaved in the wild-type clone, in clone 925 and in HeLa cells, whereas no cleavage was detected in the two mutants. Incubation of the 925 clone or HeLa cells with the poly-caspase inhibitor z-VAD-fmk prevented pump cleavage. Intact PMCA4 was still detectable in the non-mutant clones treated with STS, possibly reflecting that a fraction of the population did not undergo apoptosis. We therefore examined the subcellular distribution of the wild-type pump, and the newly expressed mutants of PMCA4 in healthy and dying cells. Confocal images show that both the wild-type human PMCA4 and the mutants were correctly targeted to the plasma membrane ( Figure 6A ). Analysis of individual cells revealed that the wild-type hPMCA4 signal disappeared from the plasma membrane in virtually all cells undergoing apoptosis (after 5 h incubation with STS) ( Figure 6B ). The hPMCA signal was fully retained in the mutants treated with STS or in wild-type cells treated with STS plus the caspase inhibitor z-VAD-fmk.
Cleavage of PMCA4 by caspases exposes a sequence that targets C-terminally-truncated pumps to the endoplasmic reticulum where they are retained and degraded. 34 Endocytosis of membrane proteins is a frequent event following secretory activity 35 and the unmasking of the PMCA sequence, which normally causes pump retention in the endoplasmic reticulum, might have promoted the internalization and subsequent degradation of the pump. Thus, we examined the subcellular localization of PMCA4 in comparison with that of the SERCA, which resides in the endoplasmic Figure 4 Identification of the cleavage site. To determine the cleavage site we examined CHO clones stably expressing full-length and truncated hPMCA4. (A) Membrane fractions prepared from four different CHO clones (wt: wild-type, 4150: vector-transfected, 925 and 10150 stably overexpressing hPMCA4) were subjected to in vitro cleavage with purified caspase-3 for 1 h at 378C. The constitutive hamster PMCAs are not recognized by the human antibody. In the 925 and 10150 clones, the degradation band reveals the same size product PMCA4* as in Sf9 membranes and in CHO cells undergoing apoptosis. (B) Membrane fractions of Sf9 cells containing full length (CI) hPMCA4 were subjected to in vitro cleavage with purified caspase-3. The Western blot was stained with antibodies against the C-terminal part of the pump (p94.2). 33 Caspase-3 generated a 25 kDa (in SDS ± PAGE) C-terminal fragment. The exact molecular mass could be slightly different, due to the very acidic character of the C-terminus of the pump, which may be responsible for an abnormal gel migration. (C) Proteins from membranes containing full-length hPMCA4 (CI) or two truncated forms (D44 and D139) were subjected to in vitro cleavage with purified caspase-3. The D44 mutant lacks the 44 C-terminal residues stretch, from amino acids phenylalanine 1162 to valine 1205. PMCA D139 lacks the amino acids glutamic acid 1067 to valine 1205. (Note that the D44 mutant migrates at higher position than expected from its molecular weight, due to the acidic character of the mutant protein). The D139 mutant was not cleaved and migrated at 118 kDa reticulum and is not cleaved by caspases. Figure 7A shows control cells, in which the red fluorescence of the PMCA pump in the cell outer rim is well separated from the green fluorescence of the SERCA pump in the cell interior. Cells showing initial features of apoptosis were selected at a time when caspase activation was detectable (4 ± 5 h after STS). As shown in the images in Figure 7 , hPMCA4 appeared to colocalize with the SERCA pump in discrete sub-membrane regions (yellow spots in Figure 7B ). In contrast, non-cleavable hPMCA4 remained localized on the plasma membrane, even in cells with condensed nuclei, while the SERCA stained the perinuclear region of cells undergoing apoptosis ( Figure  7B ,C,D and inset. Panel A shows the PMCA and SERCA distribution in untreated cells). Figure 8B ). In cells displaying initial features of apoptosis (i.e., nuclear ruffling and initial chromatin condensation), the ionomycin-induced [Ca 2+ ] i increase was not rectified at all and remained at peak levels (traces b in Figure 8A ± C). When cells were exposed to STS in the presence of z-VAD-fmk to block caspase activation, the normal, ionomycin-evoked [Ca 2+ ] i response was recovered; i.e., returned to baseline with kinetics that resembled those of the corresponding untreated clones (compare traces c with traces a in Figure 8A ± C) .
Cleavage of hPMCA4 and
Next, we examined Ca 2+ handling in the mutant CHO clones. Ca 2+ signals were again measured in untreated cells and in cells exposed to STS for 5 h. In the untreated mutants, the Ca 2+ transient triggered by ionomycin was rapidly rectified (trace a in Figure 8D ). The mutant clones undergoing apoptosis (i.e., displaying nuclear ruffling and chromatin condensation) were also able to rectify the Ca Role of PMCA cleavage in apoptosis and secondary necrosis Apoptosis and necrosis were scored in the wild-type and mutant cell clones. Apoptosis was defined by the occurrence of cells with nuclear condensation and fragmentation, retaining plasma membrane integrity (measured by exclusion of the membrane-impermeant dye, SYTOX). Primary necrosis was defined as loss of plasma membrane integrity (SYTOX penetration) without signs of nuclear condensation or fragmentation. Secondary necrosis was determined by scoring over time cells with an apoptotic morphology, which became permeable to SY-TOX. Cells were counted for up to 9 h after STS-exposure. At this time, the proportion of primary necrotic cells did not exceed 0.5% and was identical in both control and treated cells (data not shown). The percentage of apoptotic cells ranged between 30 ± 45% and did not differ extensively between cell clones at 9 h. However, at earlier time points (5 ± 7 h) the number of apoptotic cells in the mutant clones was significantly lower (up to 50% less) than that observed in the corresponding control (clone 925), showing that , were fixed and stained with a mouse monoclonal antibody recognizing the large central cytoplasmic loop of hPMCA4 and a secondary goat Alexa 2 594 antibody, which fluoresces red. The cytoplasm was stained with Cell-Tracker 2 CMFDA (green fluorescence) and nuclei were stained blue with Hoechst 33342. The localization of the pump was studied in the x/y and x/z focal planes by confocal microscopy. The pump appeared selectively localized on the cell membrane as also shown by the pixel analysis at the base of the figure. The single pixel line (a ± z) crossing a randomly selected cell was scanned using the Leica Scanware software. Numerical intensity values along the line selection for each channel were exported in Excel 2 (Microsoft, Co.) and profiles were drawn. The red line represents the localization of PMCA4, the green line shows Cell-Tracker 2 and the blue line shows Hoechst 33342 as in the images. A total of 100 cells were imaged. Representative images are shown. All scale bars correspond to 10 mm. (B) Both the 925 clone and mutant clone A were exposed to STS or to STS plus z-VAD-fmk as described above. After 5 h cells were fixed and stained with the combination of Hoechst 33342 and hPMCA4 antibodies. PMCA disappeared from the 925 clone (indicated by arrows) undergoing apoptosis (as shown by chromatin fragmentation), but remained intact in individual cells expressing the mutant hPMCA4 and in 925 cells pre-treated with z-VAD-fmk mutation of the caspase cleavage site on PMCA4 delays apoptosis ( Figure 9A ).
Between 5 and 9 h there was a marked difference in the occurrence of secondary necrosis. SYTOX-positive cells with condensed nuclei appeared in the 925 clone, whereas the mutant clones did not lyse ( Figure 9B ). To further determine whether this effect would remain significant over time we measured the cumulative release of lactate dehydrogenase (LDH) from cells. LDH-release was measured for up to 20 h after STS-exposure. As shown in Figure 9C , the mutant clone had a significantly lower LDHrelease than clone 925. Thus, the expression of noncleavable hPMCA4 mutants slows down the kinetics of apoptosis, and drastically reduces secondary necrosis.
Discussion Cleavage of PMCAs by caspases and cell death
Since cell death is not necessarily linked to a single program or a morphological phenotype, events that confer irreversibility to its execution would seal a cell's fate. Along with nuclear and cytoskeletal damage, disruption of cell signaling and ion homeostasis could warrant irreversibility to the death sentence. Inactivation of Ca 2+ -motive ATPases impairs the ability of cells to handle Ca 2+ and can lead to cell demise. 21, 36 PMCA inhibition has been implicated in neuronal cell death elicited by amyloid-b peptide 37 or in the delayed neuronal death following ischemia in CA/1 hypocampal pyramidal cells. 38 Interestingly, in the latter study, PMCA activity transiently recovered after ischemia, to decay irreversibly hours after the insult. Our findings of the cleavage of PMCA2 following ischemic brain injury may provide the explanation for these early observations. The parallel increases of pump fragmentation and the apoptotic index in vivo supports the assumption that PMCA cleavage originates with apoptosis execution. The results from the cell studies provide evidence that a sub-routine of the death program, which involves caspases and targets PMCAs, sets off secondary necrosis, promoting the rapid demise of doomed cells.
On their surface, apoptotic cells present molecules (i.e., phosphatidylserines) that trigger clearance of dying cells by phagocytes. 39, 40 Recent work in C. elegans has shown that engulfing cells triggered to die by the CED-3 caspase pathway ensures their demise, preventing a potential recovery after the initial stages of death. 41, 42 Since Ca 2+ can promote presentation of phosphatidylserines and engulfment, 29, 43 cleavage of PMCAs could seal cells' fate also by promoting their removal by phagocytes. Either the engulfment of dying cells or cell lysis, when scavenging capacity is limited, 44 could prevent the accumulation of doomed, but`undead' cells.
Caspase activation does not necessarily require elevation of intracellular Ca 2+ . Nevertheless, Ca 2+ chelators or Figure 7 The subcellular relocalization of the hPMCA and SERCA pumps during apoptosis. To examine whether hPMCA translocated to ER membranes during apoptosis, cells were fixed when initial chromatin condensation became noticeable. An Alexa 2 goat 488 secondary antibody, which fluoresces green was used to stain the SERCA pump, whereas for hPMCA4 a goat anti-mouse Alexa 2 594 was used (red fluorescence). Image A shows untreated cells, the other three images cells undergoing apoptosis after treatment with STS. In cells undergoing apoptosis (image B) the two stains co-localized (yellow stain indicated by arrows) in discrete subcellular regions. In the mutants (mutant A and mutant B in images C and D respectively) the hPMCA signal is retained intact on the plasma membrane of cells undergoing chromatin fragmentation. The SERCA pump decorated the perinuclear region probably as result of the collapse of ER membranes around the condensing nucleus (see inset)
Cell Death and Differentiation Cleavage of PMCA pumps in apoptosis BL Schwab et al channel blockers can rescue part of the death program in paradigms, where Ca 2+ is not the initial death signal. 45 Several amplification loops have been suggested between the caspase execution pathway and disturbances in intracellular Ca 2+ . These include activation of signaling proteins, 24 transcriptional factors 46 and other protease families. 29, 47 Rising Ca 2+ levels, as seen in cells where Ca 2+ extrusion is compromised, may then affect execution of apoptosis, in addition to promotion of secondary lysis. The slower kinetics of apoptosis observed in our noncleavable mutants suggest that cleavage of PMCAs can be sufficient to recruit Ca 2+ requiring pathways in the execution of apoptosis also when Ca 2+ signals are not the initial death trigger.
Cleavage site and mechanism of pump inactivation
Our findings that different PMCA isoforms are cleaved in both neurons and non-neuronal cells suggest that pump cleavage may be common to several death paradigms. Adult neurons express both PMCA2 and PMCA4, with the neuronal isoform being predominant under culture conditions. 26 Both caspases-1 and -3 may in principle be responsible for PMCA2 cleavage in vivo, since both caspases are activated in ischemic settings 3, 48 and both caspases can cleave PMCA2 in our in vitro experiments. The cleavage pattern of PMCA2 in CGN exposed to excitotoxins or in ischemic brain reveals a major 123 kDa product that is consistent with a cleavage site proximal to the C-terminus of the pump, analogous to the caspase-3 cleavage site on PMCA4. The sequence of PMCA2 shows at least two potential caspase-3 cleavage sites (1066-1072 DVEE; EEID) in the protruding C-terminus portion of the molecule that may generate the 123 kDa product. To further investigate which caspase is primarily responsible for the generation of the 123 kDa PMCA2*, we have used the selective caspase-3 inhibitor, M791. 49 Our initial experiments have shown that PMCA2 cleavage to 123 kDa is predominantly, but not completely mediated by caspase-3 (data not shown). Since the protection afforded by the pan-caspase inhibitors was complete, other caspases (i.e., caspase-1, which is active in the cleavage assay in vitro) may contribute to degradation of PMCA2. The pump fragmentation observed in the in vitro experiments is more extensive than that found in neurons and ischemic brain tissue. It is conceivable that the conditions prevailing in the in vitro cleavage experiments (i.e., concentrations of caspases and substrate) reveal additional low-affinity cleavage sites. Additional possible cleavage sites for caspases (e.g., FVLD at residues 577 ± 580) are likely to be responsible for the formation of the main 40 kDa fragment observed in vitro.
The inhibitor experiments and the analogy with the unequivocal cleavage pattern of PMCA4, strongly support the conclusion that PMCA2 cleavage in vivo is restricted to the C-terminus portion of the molecule. Our results also show that C-terminally truncated forms of the PMCA can be functionally inactive. Normally the Cterminal cytosolic portion of the pump that contains the calmodulin binding region folds close to sites near to the active center of the molecule, acting as an auto-inhibitory domain. 50 Its removal by other proteases, e.g. calpains, makes the pump constitutively active. 51 The caspase-3 cleavage site on PMCA4 is located on the N-terminal side of the calmodulin binding domain, only a few residues upstream of the activatory cleavage site by calpain. Thus, it seems unlikely that the inactivation of the pump in cells is due to conformational changes or to changes at the active site. A more plausible explanation for the complete PMCA inactivation found in our experiments is that caspase cleavage promotes its further degradation. Caspase cleavage exposes a domain with high frequency of acidic residues and a high PEST score, which facilitates pump degradation when exposed in truncated mutants. 34 Upon caspase activation, PMCA disappears from the plasma membrane of individual cells suggesting that the pump is fully degraded either in situ or after redistribution to internal compartments. Co-localization of PMCA4 and the SERCA pump in cells with initial signs of chromatin condensation suggests that the pump can be internalized within ER structures. Notably, the PMCA4 119 kDa degradation product, PMCA4* (Figure 2 ) is still capable of forming a weak phosphorylated intermediate in vitro. PMCA4* would, however, hardly function to pump Ca 2+ outside the cell as the pump appears to be removed from the plasma membrane and internalized within the ER. This is confirmed by the total loss of the ability of the cells to rectify Ca 2+ transients after caspase activation. It is remarkable that the SERCA pump remains intact until the late phases of apoptosis, when it can be seen nicely decorating the perinuclear region probably as part of the collapse of ER membranes around the nucleus. 52 Intranuclear Ca 2+ uptake is controlled in part by a Ca 2+ pump, 53 likely located on the nuclear envelope, which shares close similarity with the SERCA pump. 54 Activation of the nuclear Ca 2+ pump has been shown to promote DNA fragmentation in isolated nuclei preparations. 55 Since the SERCA pump remains active (see phosphorylation experiments), it may function to supply Ca 2+ to the perinuclear space and the nuclear interior to promote chromatin fragmentation in addition to caspase-dependent mechanisms of chromatin degradation. 21 was used to follow the extent of secondary necrosis over 20 h. The number of primary necrotic cells (i.e., SYTOX positive, without the morphological features of apoptosis) was 50.5% in all experiments. Three independent experiments comprising triple sets of data were performed. Average and standard deviation were calculated in Microsoft Excel. The differences in LDH-release between the 925 and the CHO clone mutant A were analyzed by the ANOVA test for repeated measurements. Assuming equal variance among clones, the difference proved to be significant with P=0.047 and F 1.4 =74
Inactivating cleavage of PMCA, Ca 2+ overload and neuronal survival
To balance the downhill inflow of Ca 2+ into cells and its release from intracellular stores, PMCAs remove Ca 2+ from the cytosol, maintaining the low intracellular free Ca 2+ concentration necessary to its second messenger function. Calmodulin-bound PMCA has a high affinity for Ca 2+ . Its activity is therefore quite effective to maintain or restore a low set point for cytosolic Ca 2+ . 57 Thus, PMCAs are transcriptionally regulated in differentiating CGN, most likely to fine-tune the Ca 2+ set point in post-mitotic neurons. 26 In 
PMCA cleavage and the switch apoptosis/necrosis
The mode of neuronal cell death in brain ischemia has been a matter of controversy. Evidence from stroke models suggests that necrosis predominates in the more severely stressed core area, whereas apoptotic neurons are primarily localized in the penumbra area of focal ischemia, where the insult is milder. 59, 60 The primary switch in the decision between necrosis and apoptosis depends on various factors, including the intensity of the insult, 23, 28 the degree of the initial Ca 2+ overload, 61 and the intracellular ATP levels. 7, 23 The data presented here reveal a secondary switch that may explain why necrotic features can be attributed to events that are dependent on caspase activation and downstream of the initiation of programmed cell death. Linking caspase activation to secondary necrosis provides a possible explanation for the global protective effect of caspase inhibitors in ischemia paradigms. 8 Additionally, they may further rationalize the synergistic effect of the combined treatment with caspase inhibitors and Ca 2+ channel blockers. 62 Caspases cleave only a relatively small fraction of the cellular proteome. 1 The resulting loss or gain of function gives rise to the morphological and biochemical features typical of apoptosis. However, not all substrates are equally critical for cell death. Some are part of the subroutines of the death program that may be dispensable. For example, the caspase-3 mediated degradation of ICAD 56 determines whether DNA laddering occurs in a dying cell. The latter, however, is not strictly required for cell killing or disposal, but may be relevant for an orderly burial. 63 Our finding suggests that PMCAs are vital caspase substrates and that the subroutine of the death program leading to secondary lysis is not a merely passive phenomenon. The prolonged survival of the PMCA mutants also shows that this branch of the death program requires caspase activation, and distinguishes secondary lysis from primary necrosis, which occurs by caspase-and ATP-independent mechanisms.
Materials and Methods

Neonatal hypoxic-ischemic brain injury
Neonatal P7 Sprague-Dawley rats received left common carotid artery ligation and exposure to 8% oxygen/92% nitrogen for 2.5 h. 27 The animals were returned to their cages and then euthanized 24 h later. The left (ipsilateral) and right (contralateral) cortical brain sections were dissected. The degree of injury, assessed by brain swelling, was determined for each animal and assigned a severity score from 0 (no injury) to 3 (most severe). Each cortical sample was homogenized in lysis buffer (1% (v/v) Nonidet P40, 2 mM EDTA, 50 mM Tris (pH 7.5), Roche Complete 2 protease inhibitor cocktail, and the poly-caspase inhibitor MF033) for 5 s using an Ultra-Turrax T8 homogenizer. Following 30 min of standing on ice, the lysates were clarified by centrifugation at 10 0006g for 10 min at 48C. Protein concentration was then determined using the Pierce BCA assay. Western blotting was performed using affinity-purified isoform specific rabbit anti-PMCA2 polyclonal antibodies diluted 1 : 1000. Apoptotic DNA fragmentation was quantified by assaying 10 mg of each lysate using the Roche Cell Death ELISA. For Western blot analysis, 50 mg of each lysate was loaded and subjected to electrophoresis on a 4 ± 20% gradient gel (lysates from CGN treated with PBS or 25 mM L-glutamate were included as controls; not shown). Following electrophoretic transfer to nitrocellulose, the blots were probed with 1/1000 dilution of the 2N antibody, followed by 1/5000 dilution of anti-rabbit HRP antibody. The signal was developed using the Pierce Femto substrate. A densitometric scan of the exposed film was used to quantify the level of p123 produced relative to p132.
Cell cultures
Primary cultures of mouse CGN were grown for 7 days on 12-well plates (1.2610 6 cells per well) as described previously. 30 Spodoptera frugiperda (Sf9) cells were grown in TNM-FH (Sigma, Division of Fluka, Buchs, Switzerland) and used to express full-length hPMCA2 and hPMCA4 or truncated hPMCA4s (D44 and D139) as described in detail elsewhere. 64 CHO-K1 (ATCC No. CCL 61) cells were maintained in Glasgow minimal Eagle's medium (GMEM) (GIBCO Life Technologies) supplemented with 10% dialyzed FCS, 100 mg/ml gentamicin, amino acids, nucleotides, and pyruvate. 65 HeLa S3 cells were cultured in DMEM (Dulbecco's modified Eagle medium) supplemented with 5% heath inactivated FCS, 2 mM glutamine, 100 units/ml penicillin and 100 mg/ml streptomycin.
Site directed mutagenesis and transfections
Chinese hamster ovary (CHO) cell lines transfected with the vector control (clone 4150) or overexpressing hPMCA4 (clone 925) were generated as described previously. 66 To generate hPMCA4 mutants we used a plasmid construct (pSG5-PMCA4) composed of the fulllength human cDNA (GenBank Accession #M25874) of PMCA4b excised between bp390 and 4020 from the pVL-PMCA with BamHI and KpnI, and ligated into the vector pSG5 at BamHI and KpnI restriction sites in the multiple cloning site (MCS). 67 Two different oligonucleotides were synthesized for site-directed mutagenesis of the two aspartic acid residues in the putative caspase-3 cleavage site DEID. One point mutation (adenosine ? cytosine) at bp 3636 (mutant A) or at bp 3627 (mutant B) changed the codon for aspartic acid into one for alanine, at positions 1080 or 1077, respectively. Mutagenesis was carried out using the GeneEditor 2 in vitro Site-Directed Mutagenesis System (Promega Inc. Madison, WI, USA).
The plasmids pSG5-PMCA4-D1080A and -D1077A were purified using an Endofree Maxi Kit and transfected into CHO cells via the LipofectAMINE 1 2000 Reagent (Life Technologies, Eggenstein, Germany). Transfection reagent (15 ml) and 8 mg plasmid DNA per well were incubated with CHO cells (approximately 95% confluence) in a 6-well culture plate for 4 h. The cells were co-transfected with the vector pPUR (Clontech Laboratories Inc., Palo Alto, CA, USA) to introduce resistance to puromycin. The plasmids pSG5-PMCA4 and pPUR were applied in a molar ratio of 5 : 1 to ensure selection of cells transfected with pSG5-PMCA4.
Following transfection, the cells were allowed to double under nonselective conditions for 24 h after which they were removed and plated on 10 cm petri dishes. Puromycin was added 24 h after plating at a final concentration of 5 mg/ml. Colonies were selected after 10 ± 12 days and clones expressing hPMCA4 were cultured and used for experiments between passages 5 ± 20.
Cleavage of PMCAs in excitotoxin-or staurosporine-induced apoptosis
Glutamate (60 mM) 23 or the indirect excitotoxins MPP + (50 mM) and GSNO (300 mM) 29, 30 were used to trigger apoptosis in CGNs. STS (1 mM) was used to elicit apoptosis in wt and PMCA-overexpressing CHO cells, and in HeLa cells. When chromatin condensation started to appear cells were rapidly harvested from culture plates and resuspended at a concentration of 5 ± 10610 6 /ml in a Tris/EDTA buffer (10 mM Tris/HCl, pH 8.0, 1 mM EDTA, 5 mg/ml leupeptin, 5 mg/ ml aprotinin, 5 mg/ml pepstatin). Lysis was performed by three cycles of freeze and thaw (7708/378C) and the insoluble proteins were sedimented at 15 0006g for 15 min (48C). The supernatants, which did not contain PMCAs, were discarded. The pellets were resuspended in a buffer containing 8 M urea, 0.5 M DTT, 5% SDS, 5 mM EDTA, 50 mM Tris/HCl pH 8 and bromophenol blue, and run on SDS gels. Western blotting was performed using affinity-purified isoform specific rabbit polyclonal antibodies; anti-PMCA2 antibody: diluted 1 : 1000 and anti-PMCA4 antibodies: diluted 1 : 500. 26, 68 A secondary goat anti-rabbit antibody, conjugated with alkaline phosphatase, was added in a dilution of 1 : 7500.
Cleavage of PMCAs in Sf-9 or CHO membrane fractions
Membrane fractions (600 ng protein) derived from Sf-9 cells expressing either hPMCA2 or hPMCA4 64 and from CHO cells expressing full-length or truncated hPMCA4s were incubated in an Eppendorf Thermomixer at 378C and 700 r.p.m. with 60 ng of purified caspases-1, -3, -4, -7 or -8 in a final volume of 20 ml. For caspase-1 the buffer contained 100 mM HEPES pH 7.5, 10% sucrose, and 0.1% CHAPS. A buffer containing 50 mM HEPES pH 7.5, 1% sucrose, and 0.1% CHAPS was used for the other caspases. Both buffers were supplemented with 10 mM DTT. The reaction was stopped by adding 20 ml of sample buffer (8 M urea, 0.5 M DTT, 5% SDS, 5 mM EDTA, 50 mM Tris/HCl pH 8, and bromphenol blue). The samples were separated by SDS ± PAGE (polyacrylamide gel electrophoresis). Gels were blotted on nitrocellulose using the antibodies described above.
Determination of the phosphoenzyme intermediate
The formation of the PMCA-specific phosphorylated enzyme intermediate from ATP was carried out on membrane fractions expressing hPMCA2 or hPMCA4. Membrane proteins (25 ± 50 mg) were resuspended in 50 ml of 20 mM MOPS/KOH, pH 6.8, 100 mM KCl in the presence of 100 mM Ca 2+ plus 100 mM LaCl 3 and incubated with caspase-1 or caspase-3 for up to 60 min. At each time point, the reaction was started on ice by adding 0.3 mM [ 32 P-g]-ATP (150 ± 300 Ci/mmol), followed by vigorous mixing on a Vortex. After 30 s on ice, the reaction was stopped by the addition of 7% trichloroacetic acid (TCA). Pellets were washed once in 7% TCA and 1 mM phosphate and once in water before separation on acidic gels. 69 After drying, the gels were analyzed on autoradiograms exposed to X-ray films at 7708C, for 1 ± 3 days.
Intracellular free [Ca 2+ ]
Ca 2+ transients were measured in single CHO cells by confocal microscopy. Since we were interested in the recovery kinetics following Ca 2+ transients, we used the Ca 2+ -indicator fluo-3-AM (acetoxymethylester) because of its uniform loading in CHO cells and minimal photo bleaching under the duration of our experiments. CHO cells were loaded with 15 mM fluo-3 AM for 30 min at 378C in a CSS-5 medium (120 mM NaCl, 5 mM KCl, 0.8 mM MgCl 2 , 1.8 mM CaCl 2 , 15 mM glucose, and 25 mM HEPES, pH 7.4) supplemented with 1% BSA. To ensure the complete deesterification of fluo-3, cells were washed in CSS-5 and left at room temperature for an additional 10 min. The measurements were performed at 278C using a Leica TCS-4D confocal microscope (Leica Mikrosysteme Vertrieb GmbH, Bensheim, Germany) with a 406 oil immersion lens. Fluo-3 was excited using a krypton/argon laser at a wavelength of 488 nm, and emitted fluorescence was collected using a 520 nm band pass filter. Relative mean fluorescence intensities were collected from defined regions of interest using the ion domain software (Leica Mikrosysteme Vertrieb GmbH, Bensheim, Germany). Cells were stimulated with 1 mM ionomycin. In each experiment, 45 ± 50 cells were analyzed. The recovery time after the ionomycin pulse was recorded and compared between the different clones.
PMCA localization
For immunocytochemistry, we used an antibody that recognizes an epitope in the large central cytoplasmic loop of hPMCA4 between amino acids residues 724 ± 783. 68 Staining therefore was not directly affected by the caspase cleavage of the pump, which occurs at the C-terminus. The Alexa 594 goat anti mouse IgG conjugate was used as secondary antibody (Molecular Probes Europe BV, Leiden, Netherlands). Cells were plated on glass coverslips in a 24-well culture plate and grown for 48 h. Both untreated and STS-treated cells were fixed for 15 min at room temperature using 2% PFA, 0.1% picric acid, and 5% glacial acetic acid in H 2 O. Cells were then permeabilized for 5 min with 0.1% Triton X-100 in PBS. Blocking of unspecific binding sites was performed for 1 h with 1% BSA in PBS, followed by incubation with a primary mouse antibody diluted 1 : 500 in 0.1% BSA in PBS for 1 h and with the secondary antibody, diluted 1:500 in 0.1% BSA in PBS, under the same conditions. SERCA was stained using a rabbit polyclonal antibody followed by a secondary goat anti-mouse Alexa 488 antibody. Nuclear staining was achieved using Hoechst-33342 at a final concentration of 250 ng/ml in PBS for 5 min. Cells were loaded with 1 mM fixable CellTracker 2 Green CMFDA (5-chloromethylfluorescein diacetate) to stain the cytoplasm. The probes were analyzed using a confocal microscope TCS 4D UV/VIS equipped with an argon/krypton ion laser system.
